Research + Links to Publications

1. Key studies that show reduced IVF cycles numbers and better outcomes through better management of hormone dosing. Hormone dosing control can improve egg and embryo quality, implantation success and live birth outcome.

Several published studies suggest that Individualized controlled ovarian stimulation (iCOS) should be adopted for IVF patients; this approach promises to be one of the first steps towards implementing personalized medicine in reproductive science. 

For more information please see references. 

Examples: There is published evidence that exposure to high levels of LH can lead to poor egg quality, premature ovulation, and stimulate progesterone production by the ovaries. A premature rise in progesterone may cause inappropriate maturation of the uterine lining and lead to lower chances of embryo implantation. 

  1. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.

Bosch E, Ezcurra D.Reprod Biol Endocrinol. 2011 Jun 21;9:82. 

  1. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?

Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP. Hum Reprod. 2016 Feb;31(2):370-6. 

  1. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.

Alviggi C, Humaidan P, Ezcurra D. Reprod Biol Endocrinol. 2012 Feb 6;10:9. Review.

  1. Flexible ovarian stimulation in a poor responder: a case report and literature review.

Xu B, Li Y. Reprod Biomed Online. 2013 Apr;26(4):378-83.  Review.

2. The importance for several measurements:  Therapeutic drug monitoring (TDM), is used for different type of drugs such as (Diabetes, Cardiovascular diseasekidney diseasethyroid disease, liver disease and more) but is not widely used yet in hormonal treatment. Therapeutic drug monitoring (TDM) is commonly used to help physician to maintain drug levels within the therapeutic window. The therapeutic window is the concentration range in which a drug exerts its clinical effect with minimal adverse for most patients.

1. Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles

A. Ziomkiewicz,  P.T. Ellison,  S.F. Lipson,  I. Thune,  G. Jasienska. Human Reproduction, Volume 23, Issue 11, November 2008, Pages 2555–2563.

3. Quality of life and risk: All HRT patients are at risk for Ovarian hyperstimulation syndrome (OHS) that can lead to rapid weight gain, abdominal pain, persistent nausea and vomiting, blood clots, decreased urination, shortness of breath, and increased levels of anxiety and depression. 

  1. Short and long-term risks to women who conceive through in vitro fertilization.

Tarek A Gelbaya. Hum Fertil (Camb) 2010 Mar;13(1):19-27. 

  1. An update on the prevention of ovarian hyperstimulation syndrome

Omar El TokhyJulia Kopeika, and  Tarek El-Toukhy. Womens Health (Lond). 2016 Sep; 12(5): 496–503.

  1. Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles

A. Ziomkiewicz,  P.T. Ellison,  S.F. Lipson,  I. Thune,  G. Jasienska. Human Reproduction, Volume 23, Issue 11, November 2008, Pages 2555–2563.